Réjiba S, Kechrid A
Départment des Sciences Biologiques, Faculté des Sciences de Tunis, Tunisia.
J Chemother. 2007 Aug;19(4):382-7. doi: 10.1179/joc.2007.19.4.382.
Seventy-six (75.2%) of 101 Escherichia coli isolates, collected over a 2-month period in 2002 at the Children's Hospital of Tunis (Tunisia), were resistant to at least one beta-lactam. They produced beta-lactamases which were further characterized by spectrophotometry, isoelectric focusing (IEF) and PCR. Seventy-five isolates had a pI 5.4 beta-lactamase and one isolate expressed a pI 5.6 beta-lactamase. These beta-lactamases were active against penicillins and cephalothin. Nineteen of 76 isolates were resistant to ticarcillin-clavulanic acid combination. The bla(TEM) gene was detected in 71 isolates, all expressed a pI 5.4 beta-lactamase that was assumed to be TEM-1 or inhibitor-resistant TEM (IRT). Thirty-eight of 76 isolates showed one weak band on IEF with pIs ranging from 8.2 to >9, suggesting low level expression of the chromosomal AmpC beta-lactamase. Five of 76 isolates produced extended-spectrum beta-lactamases (ESBLs), with a basic pI of 7.9 or 8.7, active on penicillins, extended-spectrum cephalosporins, but not on cefoxitin. bla(SHV) genes were detected in three isolates producing pI 7.9 ESBLs but not in two isolates expressing pI 8.7 ESBLs. These latter showed strong cefotaxime-hydrolyzing activities. Hence, they might be CTX-M-type ESBLs.
2002年,在突尼斯儿童医院为期2个月的时间里收集了101株大肠杆菌分离株,其中76株(75.2%)对至少一种β-内酰胺类抗生素耐药。它们产生了β-内酰胺酶,并通过分光光度法、等电聚焦(IEF)和聚合酶链反应(PCR)进一步进行了鉴定。75株分离株具有pI 5.4的β-内酰胺酶,1株分离株表达pI 5.6的β-内酰胺酶。这些β-内酰胺酶对青霉素和头孢噻吩有活性。76株分离株中有19株对替卡西林-克拉维酸联合制剂耐药。在71株分离株中检测到bla(TEM)基因,所有这些分离株均表达pI 5.4的β-内酰胺酶,推测为TEM-1或耐抑制剂TEM(IRT)。76株分离株中有38株在IEF上显示一条弱带,pI范围为8.2至>9,提示染色体AmpCβ-内酰胺酶低水平表达。76株分离株中有5株产生超广谱β-内酰胺酶(ESBLs),其碱性pI为7.9或8.7,对青霉素、超广谱头孢菌素具有活性,但对头孢西丁无活性。在3株产生pI 7.9 ESBLs的分离株中检测到bla(SHV)基因,但在2株表达pI 8.7 ESBLs的分离株中未检测到。后两者显示出较强的头孢噻肟水解活性。因此,它们可能是CTX-M型ESBLs。